-
Minoxidil sulphate: Reliable Assay Workflows
2026-09-10
Learn how Minoxidil sulphate (SKU C6513) can support controlled cell, vascular, and hair biology experiments through documented purity, solvent compatibility, and disciplined stock handling. This scenario-based guide connects practical assay decisions with evidence from renal vascular pharmacology.
-
4-MUG Workflow for Lysosomal Enzyme Assays
2026-09-10
4-Methylumbelliferyl-β-D-Glucopyranoside converts β-glucosidase and β-glucocerebrosidase activity into a sensitive fluorescent signal for kinetic, cell-based, and screening workflows. This practical guide connects assay design with optimized GBA1-mRNA research, emphasizing controls, pH-aware detection, and troubleshooting rather than treating fluorescence as a standalone proof of lysosomal rescue.
-
Indomethacin (A8449): Practical Assay Workflow
2026-09-09
Indomethacin (SKU A8449) is a nonsteroidal anti-inflammatory drug for controlled investigation of cyclooxygenase activity, inflammation-associated signaling, lipid metabolism, and membrane-dependent responses. This guide covers solvent selection, assay controls, storage, and interpretation limits; it should not be used to infer cell potency, therapeutic efficacy, or pathway specificity from enzyme-level product data alone.
-
Solanesol (B8776): Practical Workflow Guide
2026-09-09
Solanesol (B8776) provides a defined polyisoprenoid alcohol for biochemical workflows that require controlled handling of a hydrophobic compound. It is suitable for research applications using compatible DMSO-based preparation, but it should not be added directly to water- or ethanol-only systems and is not intended for diagnostic or medical use.
-
Chuanxiong Tissue Chemistry in Coronary Heart Disease
2026-09-08
This study distinguishes the volatile chemistry and predicted pharmacology of Chuanxiong rhizome cortex and pith in coronary heart disease research. By combining SPME-GC×GC-MS, network pharmacology, and molecular docking, it provides a tissue-resolved framework for generating hypotheses about which components and targets may contribute to therapeutic activity.
-
LDN-193189: From BMP Mechanism to Translation
2026-09-08
LDN-193189 offers a precise pharmacologic entry point into BMP receptor biology, linking ALK2/ALK3 signaling, Smad1/5/8 phosphorylation inhibition, epithelial barrier function protection, and heterotopic ossification research. This thought-leadership guide places the compound within translational assay design and carefully defines what remains untested in human neuronal models.
-
SAR131675: A VEGFR-3 Inhibitor Workflow
2026-09-07
Build cleaner lymphangiogenesis and angiogenesis assays with SAR131675, a selective ATP-competitive probe that separates VEGFR-3 biology from broader kinase effects. This workflow connects receptor phosphorylation, endothelial survival, migration, and tumor-model readouts while clarifying how nicotine–kidney research can inform, but not validate, vascular experiments.
-
Praeruptorin A: Ferroptosis Research Workflows
2026-09-07
Praeruptorin A connects Fe²⁺-centered screening with practical studies of doxorubicin cardiotoxicity, inflammation, intestinal barrier injury, and tumor-cell invasion. This workflow-focused guide explains how to prepare, dose, validate, troubleshoot, and extend the compound without confusing preclinical evidence with clinical proof.
-
Dlin-MC3-DMA LNP Workflow for RNA Delivery
2026-09-05
Dlin-MC3-DMA combines potent endosomal escape with a practical formulation workflow for siRNA and mRNA research. This guide connects hepatic gene silencing benchmarks with machine-learning-guided microglia assays, while emphasizing formulation controls, assay design, and troubleshooting.
-
Remdesivir (GS-5734) in Emerging RNA Virus Research
2026-09-04
Remdesivir (GS-5734) provides a mechanistic benchmark for RNA-dependent RNA polymerase research. This article shows how to interpret its coronavirus and filovirus data alongside a Bourbon virus mouse study without conflating assay evidence with therapeutic proof.
-
Hydroxycinnamic Acids Block COPII–STING Trafficking
2026-09-04
This study identifies the Sec24 B-site of the COPII coat complex as a molecular target of cinnamic, caffeic, and ferulic acids, linking cargo sorting to cGAS–STING-driven inflammation. Structural, cellular, and diabetic-mouse data show that disrupting STING trafficking can reduce steatosis, improve metabolic parameters, and alleviate hepatic injury, although translation beyond preclinical models remains to be established.
-
Hexamethonium Bromide: Autonomic AChR Blockade
2026-09-03
Hexamethonium Bromide is a selective antagonist of neuronal-type nicotinic AChR at autonomic ganglia. Its ganglionic blockade provides an experimental way to test autonomic contributions to cardiovascular phenotypes, including sex-dependent angiotensin II hypertension, without equating blood-pressure reduction with a single molecular mechanism.
-
Caspase-3 Activity as a Translational Decision Signal
2026-09-03
Caspase-3 activity can convert a broad cell-death phenotype into a mechanistically interpretable signal. This thought-leadership guide connects the hyperthermia–cisplatin literature with practical assay design, positioning the Caspase-3 Fluorometric Assay Kit as a functional tool for apoptosis research, pathway validation, and translational decision-making.
-
Thapsigargin: SERCA Pump Inhibitor Guide
2026-09-02
Thapsigargin is a potent SERCA pump inhibitor used to perturb intracellular calcium homeostasis and trigger endoplasmic reticulum stress. Its rapid calcium response supports calcium signaling pathway studies, while its concentration- and time-dependent cytotoxicity supports apoptosis assay development with strict research-use-only boundaries.
-
Thapsigargin as a Probe of Stress-Network Logic
2026-09-02
Thapsigargin is a potent SERCA pump inhibitor for dissecting how calcium imbalance intersects with lysosomal, metabolic, and oxidative stress. This article translates a 2024 AMPK–SQSTM1 study into a practical assay strategy that separates direct calcium effects from downstream stress-network adaptation.